AVR 0.99% $15.30 anteris technologies ltd

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-91

  1. 839 Posts.
    lightbulb Created with Sketch. 41
    Yes that is correct lex.. now Fraser's team will analyse this data (they are the experts after all) and make decisions on how/if to continue. What we had was a PowerPoint slide show that was produced over night for presentation. (If Wayne's comments are correct about the timing of receiving results). I feel the HPV trials will be arranged very differently from what they now know.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.